IN8bio
INAB
INAB
15 hedge funds and large institutions have $5.5M invested in IN8bio in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
40% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 5
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$602K | |
| 2 | +$558K | |
| 3 | +$67K | |
| 4 |
BlackRock
New York
|
+$27.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$403 |
Top Sellers
| 1 | -$492K | |
| 2 | -$61.4K | |
| 3 | -$47K | |
| 4 |
Morgan Stanley
New York
|
-$3.88K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.74K |